Skip to content

NASADAD

Login
Home
About Us
Contact Us
Mobile Menus

Search for:

Category Archives: MembersOnly

Members Only

187. Funding, Level of Care, Length of Stay etc. at Detox Facilities (1/27/16)

Image September 13, 2017 aaa

183. Sliding Fee Scales (5/2/16)

Image September 13, 2017 aaa

182. Medicaid Benefit for Buprenorphine and Drug Testing (4/18/16)

Image September 13, 2017 aaa

181. Impact of Good Samaritan Law (3/4/16)

Image September 13, 2017 aaa

203a. Buprenorphine Physicians Follow-up Inquiry (5/11/17)

Image September 13, 2017 aaa

165. MAT Induction in Jails or Prisons (7/31/17)

Image September 13, 2017 aaa

207. Experience with ASAM Continuum Software (1/19/17)

Image September 13, 2017 aaa

206. Rules or Regulations on Drug Screens and Searches in Residential Treatment Programs (11/28/16)

Image September 13, 2017 aaa

Posts navigation

← Previous 1 … 4 5 6 … 112 Next →

Sign Up for Our Weekly Newsletter

Email (required) *

First Name *

Last Name *

Company *

Select list(s) to subscribe toGeneral Interest

Example: Yes, I would like to receive emails from . (You can unsubscribe anytime)

Constant Contact Use. Please leave this field blank.

By submitting this form, you are consenting to receive marketing emails from: The National Association of State Alcohol and Drug Agency Directors (NASADAD), 1919 Pennsylvania Avenue NW, Washington, DC, 20006, http://www.nasadad.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Our Members
- Role of State Alcohol and Drug Agencies
Public Policy
Prevention
Treatment & Recovery
Resources
Job Postings
Show Member Menus

© The National Association of State Alcohol and Drug Agency Directors